A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults

Bibliographic Details
Main Authors: Mpendo, Juliet, Mutua, Gaudensia, Nyombayire, Julien, Ingabire, Rosine, Nanvubya, Annet, Anzala, Omu, Karita, Etienne, Hayes, Peter, Kopycinski, Jakub, Dally, Len, Hannaman, Drew, Egan, Michael A., Eldridge, John H., Syvertsen, Kristen, Lehrman, Jennifer, Rasmussen, Beth, Gilmour, Jill, Cox, Josephine H., Fast, Patricia E., Schmidt, Claudia
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529153/

Similar Items

Similar Items